People · Operator
Named in public records as an officer, director or promoter · active 2018–2019 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Tris Pharma, Inc. | — | Pharmaceuticals | Series D+ | $125.0M | $4.4B | 2018 |
| Aytu Bioscience, Inc | — | Pharmaceuticals | Series A | $28.8M | $309.7M | 2019 |
Ketan Mehta at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Ketan Mehta on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Green | 1 | 8 |
| Smita Mehta | 1 | 4 |
| Michael Macaluso | 1 | 4 |
| Gregory A. Gould | 1 | 4 |
| Steven Boyd | 1 | 3 |
| JOHN A. DONOFRIO JR. | 1 | 2 |
| Carl C. Dockery | 1 | 2 |
| Joshua R. Disbrow | 1 | 2 |
| Jarrett Disbrow | 1 | 2 |
| Jarrett T. Disbrow | 1 | 1 |
| Gary Cantrell | 1 | 1 |
| Carl Dockery | 1 | 1 |
| Josh Disbrow | 1 | 1 |
| Peter Ciano | 1 | 1 |
| John Donofrio Jr. | 1 | 1 |
| Gary V. Cantrell | 1 | 1 |
| Michael A. Macaluso | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.